肥胖和乳腺癌血管生成中的瘦素
Courtney B Lagarde1,2, Kapil Thapa3, Nicole M Cullen1,2
1Department of Medicine, Section of Hematology and Oncology, Tulane University School of Medicine, New Orleans, LA, United States.
Frontiers in endocrinology
|October 23, 2024
概括
肥胖在乳腺癌患者中很常见,并且与较差的结果有关. 这篇评论探讨了肥胖症中升高的勒激素如何影响血管生长 (血管生成),这对瘤进展和转移至关重要.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
- 癌症生物学 癌症生物学
背景情况:
- 大多数乳腺癌患者被诊断为超重或肥胖.
- 肥胖,其特点是高体重指数 (BMI),与较差的乳腺癌预后有关.
- 肥胖症中升高的勒丁水平 (高勒丁血症) 已知可以驱动乳腺癌转移.
研究的目的:
- 为了研究丁在调节肥胖乳腺癌患者瘤微环境中的血管生成中的作用.
- 为了阐明超血症对乳腺癌血管生成的影响,人们对其理解较少.
主要方法:
- 这项研究是对现有文献的综述.
- 它侧重于连接乳腺癌中瘦素,肥胖和血管生成的生物机制.
- 这篇评论考察了瘤微环境的作用.
主要成果:
- 素是促进血管生成的关键因素,对于1mm3.3以上的瘤生长至关重要.
- 肥胖患者的超血可能会显著影响乳腺癌血管生成.
- 了解这种联系对于开发有针对性的疗法至关重要.
结论:
- 素在乳腺癌血管生成中起着重要作用,特别是在肥胖的背景下.
- 对莱普丁血管新生效应的进一步研究可能会为肥胖乳腺癌患者带来新的治疗策略.
- 准勒丁信号传递可能是改善这一患者群体治疗结果的一种方式.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Obesity
387
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
387
Mechanism of Angiogenesis
5.3K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.3K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K


